Picture of AbCellera Biologics logo

ABCL — AbCellera Biologics News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousLarge CapHigh Flyer

Abcellera Biologics Inc reports results for the quarter ended in September 30 - Earnings Summary

* Abcellera Biologics Inc  ABCL.OQ  reported a quarterly
adjusted
loss of 17 cents​​ per share for the quarter ended September 30,
lower than the same quarter last year, when the company reported
EPS of -10 cents.  The mean expectation of nine analysts for the
quarter was for a loss of 15 cents per share. Wall Street
expected results to range from -17 cents to -13 cents per share.
    * Revenue fell 1.4% to $6.51 million from a year ago;
analysts
expected $7.95 million. 
    * Abcellera Biologics Inc's reported EPS for the quarter was
a
loss of 17 cents​.
    * The company reported a quarterly loss of $51.11 million.
    * Abcellera Biologics Inc shares had risen by 11.2% this
quarter and lost 49.4% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts had risen by
about 3.2%
in the last three months.​ 
    * In the last 30 days, there have been no negative revisions
of
earnings estimates

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 8 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the biotechnology
&
medical research peer group is also "buy"

Wall Street's median 12-month price target for Abcellera
Biologics Inc is 11.00 
This summary was machine generated from LSEG data November 5 at
07:58 a.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Sep. 30 2024      -0.15          -0.17          Missed
 Jun. 30 2024      -0.14          -0.13          Beat
 Mar. 31 2024      -0.17          -0.14          Beat
 Dec. 31 2023      -0.13          -0.17          Missed

Recent news on AbCellera Biologics

See all news